138 related articles for article (PubMed ID: 36792801)
41. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
42. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.
Artemaki PI; Sklirou AD; Kontos CK; Liosi AA; Gianniou DD; Papadopoulos IN; Trougakos IP; Scorilas A
Clin Biochem; 2020 Jan; 75():62-69. PubMed ID: 31672651
[TBL] [Abstract][Full Text] [Related]
43. An optimal mRNA marker for OSNA (One-step nucleic acid amplification) based lymph node metastasis detection in colorectal cancer patients.
Yamamoto N; Daito M; Hiyama K; Ding J; Nakabayashi K; Otomo Y; Tsujimoto M; Matsuura N; Kato Y
Jpn J Clin Oncol; 2013 Mar; 43(3):264-70. PubMed ID: 23293371
[TBL] [Abstract][Full Text] [Related]
44. Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer.
Yu H; Han L; Yuan J; Sun Y
Cancer Biomark; 2020; 27(1):29-37. PubMed ID: 31658042
[TBL] [Abstract][Full Text] [Related]
45. Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.
Osumi H; Shinozaki E; Takeda Y; Wakatsuki T; Ichimura T; Saiura A; Yamaguchi K; Takahashi S; Noda T; Zembutsu H
Cancer Med; 2019 Jan; 8(1):408-417. PubMed ID: 30575318
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
47. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
48. Spastic Paraplegia 20 and Serine/Threonine Protein Kinase 31 Expression for the Detection of Colorectal Cancer.
Hassan NA; Idriss NK; Gaber N; Ibrahim A; Tawfeek MA; Mossad E; Mosa AA; Ahmed EH; Sayed SA; Ahmed HA; Mohamed AAM
Cell Physiol Biochem; 2022 Apr; 56(2):138-149. PubMed ID: 35389570
[TBL] [Abstract][Full Text] [Related]
49. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.
Herreros-Villanueva M; Duran-Sanchon S; Martín AC; Pérez-Palacios R; Vila-Navarro E; Marcuello M; Diaz-Centeno M; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; José Lozano J; García-Cougil M; Martínez-Arranz I; Castells A; Gironella M; Arroyo R
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00003. PubMed ID: 30702491
[TBL] [Abstract][Full Text] [Related]
50. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer.
Zhu MC; Xu YJ; Zou X; Yan F
Int J Colorectal Dis; 2012 Jan; 27(1):31-6. PubMed ID: 21947186
[TBL] [Abstract][Full Text] [Related]
52. Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer.
Mai D; Zheng Y; Guo H; Ding P; Bai R; Li M; Ye Y; Zhang J; Huang X; Liu D; Sui Q; Pan L; Su J; Deng J; Wu G; Li R; Deng S; Bai Y; Ligu Y; Tan W; Wu C; Wu T; Zheng J; Lin D
Theranostics; 2020; 10(19):8468-8478. PubMed ID: 32754257
[No Abstract] [Full Text] [Related]
53. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
54. Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLC.
Chang JW; Shih CL; Wang CL; Luo JD; Wang CW; Hsieh JJ; Yu CJ; Chiou CC
Cancer Genomics Proteomics; 2020; 17(1):91-100. PubMed ID: 31882554
[TBL] [Abstract][Full Text] [Related]
55. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
56. The long noncoding RNA CTA-941F9.9 is frequently downregulated and may serve as a biomarker for carcinogenesis in colorectal cancer.
Guo Z; Zhou C; Zhong X; Shi J; Wu Z; Tang K; Wang Z; Song Y
J Clin Lab Anal; 2019 Nov; 33(9):e22986. PubMed ID: 31343781
[TBL] [Abstract][Full Text] [Related]
57. Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.
Yadegarazari R; Hassanzadeh T; Majlesi A; Keshvari A; Monsef Esfahani A; Tootoonchi A; Shabab N; Saidijam M
Iran Biomed J; 2013; 17(1):15-21. PubMed ID: 23279830
[TBL] [Abstract][Full Text] [Related]
58. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
59. Identification of MSX1 and DCLK1 as mRNA Biomarkers for Colorectal Cancer Detection Through DNA Methylation Information.
Sun AJ; Gao HB; Liu G; Ge HF; Ke ZP; Li S
J Cell Physiol; 2017 Jul; 232(7):1879-1884. PubMed ID: 27966796
[TBL] [Abstract][Full Text] [Related]
60. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
